This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

People using weight loss jabs could be at risk of several side effects that happen in around “one in 10”. According to experts, these issues can be “very common”. Weight loss medications are also ...

Here's what you need to know about the potential side effects of weight loss medications ...

Medical professionals warned of very common side effects affecting roughly one in 10 users ...

There are two diabetes medications that are also used for weight loss – Rybelsus and Ozempic. They both contain the same drug called Semaglutide, Rybelsus is an oral medication whereas Ozempic is an ...

Humulin R U-100, which contains 100 units of insulin per milliliter (100 units/mL) Humulin R U-500, which contains 500 units/mL If you and your doctor agree Humulin R is safe and working well for you, ...

An NHS doctor has issued a warning about the "most common" side effect experienced by patients using weight loss injections ...